Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development
NANJING, China, Sept. 1, 2026 /PRNewswire/ — Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK…
Press Releases by PR Newswire
Global-Leading Robobrain Firm Mech-Mind Robotics Lists on Hong Kong Stock Exchange
SHANGHAI, Sept. 1, 2026 /PRNewswire/ — Mech-Mind Robotics, a portfolio company of Qiming Venture Partners and a glo…
XO Sports Xplodes into the USA
The Australian AI predictions platform that called four out of five underdogs in the NBA Finals has landed on American so…
Time is Running Out to Submit a Claim in the Asbestos Corporation Limited insolvency proceedings
The deadline is September 10, 2026. NEW YORK, Sept. 1, 2026 /PRNewswire/ — The following statement is being issued …
Ribbon Bolsters Its Market-Leading Critical Infrastructure Portfolio
New generation of routers delivers expanded routing, automation, security and synchronization capabilities PLANO, Texas, …
QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
Joint test on IonQ Forte hardware lands within 4% of benchmark, clearing the chemical-accuracy bar for enzyme active-site…
Binance Adds U.S. Stock Options to its Multi-Asset Platform
Building on its U.S. equities offering, Binance expands access to options on selected U.S. stocks and ETFs ABU DHABI, UAE…
Malaysia's BFSI Technology Leaders to Convene at the 39th Edition BFSI IT Summit Malaysia 2026
Summit to Bring Together More Than 150 CIOs, CTOs, CISOs and Digital Innovation Leaders to Explore Trust, Resilience and …
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Ad…
Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Signi…
Malaysia's Cybersecurity Leaders to Convene at the 34th Edition Cyber Security Summit Malaysia 2026
Summit to Bring Together More Than 150 CISOs, CIOs, Government Officials and Cybersecurity Leaders to Explore Identity, I…
OncoC4 Appoints Dr. Steve Chen, JD, PhD as General Counsel
ROCKVILLE, Md., Sept. 1, 2026 /PRNewswire/ — OncoC4, Inc., a late clinical-stage biopharmaceutical company developi…
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
Strength across the company’s largest franchises, new growth platforms, and recent portfolio investments support th…
ICAC Commissioner in Vienna to meet new UNODC Chief to foster anti-corruption strategic collaboration and unveil ICAC's AI enforcement system "Tianma" at UNODC's anti-graft conference
VIENNA, Sept. 1, 2026 /PRNewswire/ — ICAC Commissioner Mr Woo Ying-ming concluded a five-day visit to Vienna, Austr…
Autoware Foundation Partners with Renesas to Accelerate Production-Ready End-to-End AI for ADAS and Autonomous Driving
Highlights: Renesas joins the Autoware Foundation to accelerate development of pre–integrated ADAS and autonomous driving…
TERREPOWER to Showcase a Wide Range of Innovative Aftermarket Solutions at Automechanika Frankfurt 2026
BAAR, Switzerland, Sept. 1, 2026 /PRNewswire/ — TERREPOWER, formerly BBB Industries, a global leader in sustainable…
